Webinar: Noninvasive Prenatal Testing: The Luna Prenatal Test for Isolation of Circulating Fetal Cells Early in Pregnancy

For decades, many groups around the world have pursued the isolation and genetic analysis of circulating fetal cells from maternal peripheral blood as an improved form of noninvasive prenatal testing. However, the exceeding rarity of these cells in the blood of pregnant women has proven a challenging obstacle in the establishment of a reliable test methodology. The ability to successfully isolate and sort low-volume and rare cell populations with Namocell™ single cell sorters could be the key to overcoming this obstacle.

Join Mason Ouren, R&D Scientist from Luna Genetics to learn about a breakthrough in the reliable isolation and successful analysis of circulating fetal cells for noninvasive prenatal testing early in pregnancy. The webinar will include the path taken to establish the Luna Prenatal Test methodology, data from key validation cases and the future trajectory of the test.

What You Will Learn:

• Historic challenges to the establishment of a noninvasive cell-based prenatal test
• How the Luna Prenatal Test isolates and analyzes single circulating fetal cells early in pregnancy
• How the Luna Prenatal Test makes a positive difference in patient care and reproductive health